ILCA 2024 Reveals: Sorafenib-Toripalimab and Anlotinib-Sintilimab Combos Yield Unprecedented Results in Liver Cancer
Editor’s Note: From October 17-19, 2024, global experts and scholars in liver cancer research gathered in Toronto, Canada, to witness the 18th International Liver Cancer Association (ILCA) Annual Conference. At…